{"title":"2017牛津糖尿病研讨会。","authors":"A. Krentz","doi":"10.1097/XCE.0000000000000137","DOIUrl":null,"url":null,"abstract":"The 2017 annual Oxford Diabetes Symposium was held at Keble College on 20th and 21st July. The event, which is by invitation and focused on senior diabetes specialist clinicians, was organized by Oxford physicians Dr Garry Tan and Dr Jonathan Levy. As usual, the symposium was supported by an unrestricted educational grant from Novo Nordisk (who have recently announced a major collaboration on type 2 diabetes research with the University of Oxford).","PeriodicalId":72529,"journal":{"name":"Cardiovascular endocrinology","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oxford Diabetes Symposium 2017.\",\"authors\":\"A. Krentz\",\"doi\":\"10.1097/XCE.0000000000000137\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The 2017 annual Oxford Diabetes Symposium was held at Keble College on 20th and 21st July. The event, which is by invitation and focused on senior diabetes specialist clinicians, was organized by Oxford physicians Dr Garry Tan and Dr Jonathan Levy. As usual, the symposium was supported by an unrestricted educational grant from Novo Nordisk (who have recently announced a major collaboration on type 2 diabetes research with the University of Oxford).\",\"PeriodicalId\":72529,\"journal\":{\"name\":\"Cardiovascular endocrinology\",\"volume\":\"37 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/XCE.0000000000000137\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/XCE.0000000000000137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The 2017 annual Oxford Diabetes Symposium was held at Keble College on 20th and 21st July. The event, which is by invitation and focused on senior diabetes specialist clinicians, was organized by Oxford physicians Dr Garry Tan and Dr Jonathan Levy. As usual, the symposium was supported by an unrestricted educational grant from Novo Nordisk (who have recently announced a major collaboration on type 2 diabetes research with the University of Oxford).